Head, Oncology Clinical Development - ADCs

Key Responsibilities & Accountabilities

• Accountable for end-to-end clinical development of an MOA-focused, multi-tumor asset, including registrational trials, regulatory approval, and initial market launch, ensuring scientific rigor, speed, and quality of execution.
• Shape and drive the scientific and clinical development strategy for the asset and disease areas, aligned with Oncology Tumor Team strategy and broader Oncology portfolio priorities.
• Evaluate, champion, and enable the use of novel approaches (e.g., AI/ML, innovative trial designs, external and real-world data sources) where they add clear scientific, operational, or decision-making value to clinical development.
• Provide oversight and connectedness across the asset program, maintaining visibility to progress, risks, dependencies, and trade-offs across the Oncology portfolio.
• Represent the Oncology Clinical Development organization internally and externally, including presenting at high-impact forums such as congress all-hands, senior leadership reviews, and advisory boards.
• Lead scientific advisory boards and other external engagements to inform asset strategy, competitive positioning, and portfolio decisions, incorporating emerging science and external expert insight.
• Act as a senior connector across functions, partnering closely with Oncology Research, Precision Medicine/Companion Diagnostics, Medical Affairs, Commercial, Competitive Intelligence, and Global Product Strategy to drive integrated development and lifecycle planning.
• Build and sustain strong internal and external partnerships to accelerate decision-making, resolve complexity, and optimize development outcomes in a matrixed environment.
• Foster a culture of empowerment, scientific excellence, inclusion, and collaboration, aligned with OneOncology values, while modeling strong, visible leadership.
• Contribute to the establishment and continuous evolution of clinical development standards, processes, and best practices across Oncology, ensuring consistency, quality, and regulatory readiness.
• Ensure timely access to relevant external scientific and competitive intelligence (e.g., congress data, emerging science, competitor activity) to inform clinical development decisions and portfolio strategy.

Skills & Capabilities

• Senior clinical and scientific leadership in early- and focused late-phase oncology drug development, including FTIH through registrational trials and launch readiness.
• Strong ability to translate science and translational insight into differentiated clinical development strategies across disease areas and portfolios.
• Proven capability to operate at portfolio level, balancing priorities, risk, and resources while maintaining asset-level rigor and accountability.
• Credibility and effectiveness representing Clinical Development at senior governance forums, with strong executive presence and influence.
• Advanced cross-functional and matrix leadership skills, with a natural connector mindset across research, development, medical, commercial, and precision medicine partners.
• Openness to and fluency with innovative development approaches (e.g., AI/ML, novel trial designs, external and real-world data) where they add value.
• Commitment to fostering a culture of scientific excellence, empowerment, inclusion, and continuous improvement in a complex global environment.

Basic Qualifications

• Md, MBBS, MBChB or international equivalent medical degree.
• Board certification/eligibility or registration in a primary or medical specialty.
• Oncology drug development experience in the pharmaceutical industry.
• Leadership experience of early- and focused late-phase oncology development programs from first-in-human through registrational studies and launch readiness.
• Experience leading Antibody Drug Conjugate or other targeted oncology development programs.
• Experience holding accountability for asset-level or portfolio-level clinical development strategy, governance, and execution.
• Experience interacting with global health authorities and supporting regulatory submissions and approvals.
• Experience leading global cross-functional teams in complex matrix environments.

Preferred Qualifications

• Board certification/eligibility or registration in medical oncology, hematology/oncology.
• Strong experience in governance leadership, scientific narrative ownership, portfolio influence, and executive-level decision-making.
• Experience in translational research, including the application of translational science to inform clinical development strategies and decision-making.
• Experience utilizing innovative development approaches, including advanced analytics, AI/ML, real-world evidence, or novel trial design.